Authors: Evene, E Brault, M Manche, M Sibille, M Montay, G Durand, DV

Citation: E. Evene et al., Bioequivalence study of two formulations (Sachet and tablet) of cefixime after single oral doses of 200mg in healthy male volunteers, CLIN DRUG I, 21(4), 2001, pp. 287-294

Authors: Durupt, S Josserand, RN Sibille, M Durieu, I

Citation: S. Durupt et al., Acute, recurrent fosfomycin-induced liver toxicity in an adult patient with cystic fibrosis, SC J IN DIS, 33(5), 2001, pp. 391-392

Authors: Zenone, T Steineur, MP Sibille, M Durieu, I Durand, DV

Citation: T. Zenone et al., Myelopathy as a first manifestation of systemic lupus erythematosus: two cases and literature review, REV MED IN, 21(12), 2000, pp. 1114-1120

Authors: Zannikos, PN Rohatagi, H Jensen, BK DePhillips, SL Massignon, D Calic, F Sibille, M Kirkesseli, S

Citation: Pn. Zannikos et al., Pharmacokinetics, pharmacodynamics, and safety of a platelet GPIIb/IIIa antagonist, RGD891, following intravenous administration in healthy male volunteers, J CLIN PHAR, 40(11), 2000, pp. 1245-1256

Authors: Sibille, M Durieu, I Durand, DV

Citation: M. Sibille et al., Elevated liver enzymes in asymptomatic patients, N ENG J MED, 343(9), 2000, pp. 662-662

Authors: Sibille, M Deigat, N Durieu, I Guillaumont, M Morel, D Bienvenu, J Massignon, D Durand, DV

Citation: M. Sibille et al., Laboratory data in healthy volunteers: reference values, reference changes, screening and laboratory adverse event limits in phase I clinical trials, EUR J CL PH, 55(1), 1999, pp. 13-19